RUNX1 and glioblastoma: Here, the present study identified miR-128-3p as a negative regulator of RUNX1 and validated their functional interaction in TMZ sensitivity of GBM cells, suggesting that miR-128-3p/RUNX1 axis could serve as a potential therapeutic target in TMZ-resistant GBM.